Cardio Vascular Dynamics (CVD) to develop Facilitated Force Angioplasty:
This article was originally published in Clinica
Endosonics subsidiary Cardio Vascular Dynamics (US) has licensed the exclusive, worldwide rights to Facilitated Force Angioplasty (FFA) technology which uses a novel catheter design for controlled incision of atherosclerotic plaque. The technology mechanically controls the scoring and cutting of artherosclerotic plaque so that conventional angioplasty can be carried out. The California-based company has agreed to finalise the development of FFA, complete clinical trials and obtain worldwide marketing approvals. FFA was developed by Dr Michael Stillabower, a practising interventional cardiologist at the Medical Center of Delaware, California.